Abstract:The host always employs various ways to defend against viral infection and spread. However, viruses have evolved their own effective strategies, such as inhibition of RNA translation of the antiviral effectors, to destroy the host's defense barriers. Protein synthesis, commonly controlled by the α-subunit of eukaryotic translation initiation factor 2 (eIF2α), is a basic cellular biological process among all species. In response to viral infection, in addition to inducing the transcription of antiviral cytokines by innate immunity, infected cells also inhibit the RNA translation of antiviral factors by activating the protein kinase R (PKR)-eIF2α signaling pathway. Regulation of innate immunity has been well studied; however, regulation of the PKR-eIF2α signaling pathway remains unclear. In this study, we found that the E3 ligase TRIM21 negatively regulates the PKR-eIF2α signaling pathway. Mechanistically, TRIM21 interacts with the PKR phosphatase PP1α and promotes K6-linked polyubiquitination of PP1α. Ubiquitinated PP1α augments its interaction with PKR, causing PKR dephosphorylation and subsequent translational inhibition release. Furthermore, TRIM21 can constitutively restrict viral infection by reversing PKR-dependent translational inhibition of various previously known and unknown antiviral factors. Our study highlights a previously undiscovered role of TRIM21 in regulating translation, which will provide new insights into the host antiviral response and novel targets for the treatment of translation-associated diseases in the clinic. Transcriptional induction of antiviral cytokines, especially interferons (IFNs), is a hallmark of innate immunity upon viral infection. In addition, viral infection can inhibit RNA translation of the antiviral factors by activating the PKR-eIF2α axis. Regulation of the innate immune signaling pathway has been well studied. However, regulation of the PKR signaling pathway remains unclear. Our previous study demonstrated that TRIM21, an E3 ligase, positively regulates the innate immune response by catalyzing K27-linked ubiquitination of MAVS. However, whether TRIM21 regulates the PKR signaling pathway is unknown. In this study, we found that TRIM21 can negatively regulate PKR activation by promoting K6-linked ubiquitination of the PKR phosphatase PP1α, contributing to the enhancement of the PKR-PP1α interaction, which leads to dephosphorylation of PKR. Moreover, our study identified various previously known and unknown antiviral factors regulated by the TRIM21-PKR axis. Our study highlights TRIM21-mediated PKR-dependent RNA translation in the antiviral response, which may provide a target for the treatment of translation-associated diseases in the clinic.

TRIM21 is Essential to Sustain IFN Regulatory Factor 3 Activation During Antiviral Response

TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury Via Interacting with MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production

TRIM26 negatively regulates interferon-β production and antiviral response through polyubiquitination and degradation of nuclear IRF3.

Association of TRIM22 with the Type 1 Interferon Response During Primary Human Cytomegalovirus Infection in THP-1 Macrophages

TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1

TRIM21 reduces H1N1-induced inflammation and apoptosis by regulating the TBK1–IRF3 signaling pathway in A549 cells

Multiple Roles of TRIM21 in Virus Infection

TRIM65 regulates innate immune signaling by enhancing K6-linked ubiquitination of IRF3 and its chromatin recruitment

TRIM24 Facilitates Antiviral Immunity Through Mediating K63-linked TRAF3 Ubiquitination

Tripartite Motif-Containing (TRIM) 21 Negatively Regulates Intestinal Mucosal Inflammation Through Inhibiting TH1/TH17 Cell Differentiation in Patients with Inflammatory Bowel Diseases.

TRIM21 Promotes Innate Immune Response to RNA Viral Infection Through Lys27-Linked Polyubiquitination of MAVS

TRIM28 facilitates type I interferon activation by targeting TBK1

Systems genetics of influenza A virus-infected mice identifies TRIM21 as a critical regulator of pulmonary innate immune response

TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO

A 5′ Extended IFN-Stimulating Response Element is Crucial for IFN-γ–Induced Tripartite Motif 22 Expression Via Interaction with IFN Regulatory Factor-1

Regulation of PKR-dependent RNA translation inhibition by TRIM21 upon virus infection or other stress

TRIM38 Induced in Respiratory Syncytial Virus-infected Cells Downregulates Type I Interferon Expression by Competing with TRIM25 to Bind RIG-I

Trim32 Protein Modulates Type I Interferon Induction and Cellular Antiviral Response by Targeting Mita/Sting Protein for K63-Linked Ubiquitination

Autoubiquitination of TRIM26 Links TBK1 to NEMO in RLR-mediated Innate Antiviral Immune Response.

TRIM14 Expression is Regulated by IRF‐1 and IRF‐2

Impaired Antiviral Responses to Extracellular Double-Stranded RNA and Cytosolic DNA, but Not to Interferon-α Stimulation, in TRIM56-Deficient Cells.